These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8973995)

  • 1. Lack of pharmacokinetic interaction after administration of lansoprazole or omeprazole with prednisone.
    Cavanaugh JH; Karol MD
    J Clin Pharmacol; 1996 Nov; 36(11):1064-71. PubMed ID: 8973995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of interaction between lansoprazole and propranolol, a pharmacokinetic and safety assessment.
    Karol MD; Locke CS; Cavanaugh JH
    J Clin Pharmacol; 2000 Mar; 40(3):301-8. PubMed ID: 10709160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction between lansoprazole and theophylline.
    Granneman GR; Karol MD; Locke CS; Cavanaugh JH
    Ther Drug Monit; 1995 Oct; 17(5):460-4. PubMed ID: 8585108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction between acetaminophen and lansoprazole.
    Sanaka M; Kuyama Y; Mineshita S; Qi J; Hanada Y; Enatsu I; Tanaka H; Makino H; Yamanaka M
    J Clin Gastroenterol; 1999 Jul; 29(1):56-8. PubMed ID: 10405233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline.
    Dilger K; Zheng Z; Klotz U
    Br J Clin Pharmacol; 1999 Sep; 48(3):438-44. PubMed ID: 10510158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
    Dammann HG; Fuchs W; Richter G; Burkhardt F; Wolf N; Walter TA
    Aliment Pharmacol Ther; 1997 Apr; 11(2):359-64. PubMed ID: 9146776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects.
    Harder H; Teyssen S; Stephan F; Pfützer R; Kiel G; Fuchs W; Singer MV
    Scand J Gastroenterol; 1999 Jun; 34(6):551-61. PubMed ID: 10440603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin.
    Karol MD; Locke CS; Cavanaugh JH
    J Clin Pharmacol; 1999 Dec; 39(12):1283-9. PubMed ID: 10586395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.
    Saito M; Yasui-Furukori N; Uno T; Takahata T; Sugawara K; Munakata A; Tateishi T
    Br J Clin Pharmacol; 2005 Mar; 59(3):302-9. PubMed ID: 15752376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction between proton pump inhibitors and roxithromycin in volunteers.
    Kees F; Holstege A; Ittner KP; Zimmermann M; Lock G; Schölmerich J; Grobecker H
    Aliment Pharmacol Ther; 2000 Apr; 14(4):407-12. PubMed ID: 10759619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.
    Vakily M; Lee RD; Wu J; Gunawardhana L; Mulford D
    Clin Drug Investig; 2009; 29(1):35-50. PubMed ID: 19067473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline.
    Pan WJ; Goldwater DR; Zhang Y; Pilmer BL; Hunt RH
    Aliment Pharmacol Ther; 2000 Mar; 14(3):345-52. PubMed ID: 10735929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
    Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
    J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lansoprazole pharmacokinetics differ in patients with oesophagitis compared to healthy volunteers.
    Barclay ML; Begg EJ; Robson RA; Peters WA; Ketelbey JW
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1215-9. PubMed ID: 10468704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve.
    Niioka T; Yasui-Furukori N; Uno T; Sugawara K; Kaneko S; Tateishi T
    Ther Drug Monit; 2006 Jun; 28(3):321-5. PubMed ID: 16778714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of oral doses of lansoprazole and omeprazole on gastric pH.
    Tolman KG; Sanders SW; Buchi KN; Karol MD; Jennings DE; Ringham GL
    J Clin Gastroenterol; 1997 Mar; 24(2):65-70. PubMed ID: 9077718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
    Frelinger AL; Lee RD; Mulford DJ; Wu J; Nudurupati S; Nigam A; Brooks JK; Bhatt DL; Michelson AD
    J Am Coll Cardiol; 2012 Apr; 59(14):1304-11. PubMed ID: 22464259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
    Müller P; Göksu MA; Fuchs W; Schlüter F; Simon B
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1225-9. PubMed ID: 10971240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.